http://www.fibrogen.com
FibroGen, Inc. Company Intro
FibroGen creates first-in-class medicines to treat chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis, and pancreatic cancer.
Industry
Healthcare
FibroGen, Inc. Headquaters
409 Illinois Street
San Francisco,94158
United States
FibroGen, Inc. Share price
09 Apr 2021 01:40 GMT
$19.36
-0.38 (-1.93 %)
FibroGen, Inc. Market cap
$1.722 B
WMC RANKING
2021
FibroGen, Inc. # 52
BiotechnologyLatest FibroGen, Inc. News
02 Apr 2021
Connective Tissue Growth Factor Market to Witness Huge ...
Published By: Read Market Research Pvt. Ltd. ... Top Companies in this report includes: FibroGen Inc, ProMetic Life Sciences Inc, RXi Pharmaceuticals Corp, ...
02 Apr 2021
Surgical Headlights Market explored in the latest research ...
Published By: Read Market Research Pvt. Ltd. ... Medical, Orascoptic, STILLE, Cuda Surgical, BFW, PeriOptix Inc., VOROTEK, Enova, OSRAM GmbH. ... Tissue Growth Factor Market to Witness Huge Growth by 2027 | FibroGen Inc, ProMetic ...
02 Apr 2021
Idiopathic Pulmonary Fibrosis Drug Market and Ecosystem ...
... Medicinova, Inc., Cipla, Boehringer Ingelheim GMBH, Galapagos NV, Bristol-Myers Squibb Company, Novartis AG, Fibrogen, Inc., Hoffmann-La Roche AG, ...
WMC Market Score
WMC Market to Revenue Score
FibroGen, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| FibroGen, Inc. | USD | $119,294 | $346,454 | $-228,780 | $17,220B | 52 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $510,330B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,205,683 | $2,599,993 | $2,711,647 | $546,640B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,069,900 | $2,656,500 | $603,400 | $339,600B | 3 |
| Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $177,700B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total FibroGen, Inc. Social Followers vs Top 4 Industry Competitors
FibroGen, Inc. Post vs Top 4 Industry Competitors
FibroGen, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
FibroGen, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
FibroGen, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| FibroGen, Inc. | 1.97 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 100 | 100 | 0 | 0 | 0 | 100 |
| Incyte Corporation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
